Clinical Trials Logo

Filter by:
NCT ID: NCT06431724 Enrolling by invitation - Cervical Cancer Clinical Trials

A Review of Cervical Cancer Screening Practices in Women Age >65

Start date: July 31, 2023
Phase:
Study type: Observational

The goal of this research study is to examine adherence to national guidelines for cervical cancer screening in women age >65. Patient surveys will provide information about women age >65 current cervical screening practices and allow researchers to compare that information to national recommended guidelines regarding cervical screenings. Provider surveys will provide information from surveyed providers about screening knowledge and current provider practices for women patients > 65 for cervical cancer. The results may be used to make future recommendations for improving gynecological care and to help develop effective strategies for ensuring guideline adherence.

NCT ID: NCT06431607 Recruiting - Influenza, Human Clinical Trials

A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adults

Start date: May 23, 2024
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and immune response of GlaxoSmithKlines (GSK) messenger RNA (mRNA)-based multivalent vaccine (GSK4382276A) candidate against influenza, administered in healthy younger adults (YA) and older adults (OA).

NCT ID: NCT06431594 Not yet recruiting - Solid Tumors Clinical Trials

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Participants With Advanced Solid Tumors

Start date: June 21, 2024
Phase: Phase 1
Study type: Interventional

The goal of this study is to assess the safety and tolerability of GSK5733584. The study will also see how the levels of GSK5733584 change over time at different dose amount.

NCT ID: NCT06431347 Recruiting - Clinical trials for Transplant and Cell Therapy

Prospective Observational Cohort Study of Transplant and Cell Therapy Candidates and Recipients to Assess Social Determinants of Health

Start date: June 17, 2024
Phase:
Study type: Observational

To learn more about social and financial factors that may influence outcomes of TCT treatment at MD Anderson.

NCT ID: NCT06431295 Not yet recruiting - Visual Acuity Clinical Trials

Evaluation of a Digital Visual Acuity Device vs. Standard Visual Acuity Measurements

Start date: June 2024
Phase: N/A
Study type: Interventional

The purpose of this research is to validate and determine the accuracy of the experimental device when measuring visual acuity versus our standard visual acuity measurements and to gather voice recordings of letters to help build a special system that recognizes spoken letters.

NCT ID: NCT06431074 Recruiting - Anxiety Clinical Trials

Radicle Calm 24: A Study of Health and Wellness Products on Feelings of Anxiety and Related Health Outcomes

Start date: May 30, 2024
Phase: N/A
Study type: Interventional

A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on feelings of anxiety and related health outcomes

NCT ID: NCT06431048 Not yet recruiting - Tracheostomy Clinical Trials

No DIET Trial: Dogmatic Interruption of Enteral nuTrition

Start date: June 2024
Phase: N/A
Study type: Interventional

There is currently limited guidance on when to hold nutritional supplementation through for patients, who are receiving tube feeding, undergoing surgical procedures. This study aims to investigate which time would be the best to stop nutrition, if at all, before undergoing a surgical procedure.

NCT ID: NCT06430905 Not yet recruiting - Clinical trials for Human Immunodeficiency Virus (HIV) Infection

Safety, Reactogenicity and Immunogenicity of HB-502 and HB-501 Versus Placebo in People With HIV on Suppressive ART

Start date: June 2024
Phase: Phase 1
Study type: Interventional

This is a study of HB-502 and HB-501 alternating 2-vector therapy in people living with human immunodeficiency virus (HIV) who are taking antiretroviral treatment (ART). The benefits of available ART are short-lived and eventually there is a return of rapid HIV replication and higher viral copy number after a period of initial improvement of infection. The study treatment made of HB-502 and HB-501 is designed to train the body to recognize and fight parts from substances found in HIV. This trial studies the safety, tolerability, and ability of HB-502 and HB-501 to stimulate an immune response against HIV in people living with HIV. Participants will receive the study treatment by injection into the muscle every 8 weeks for a duration of 24 weeks, which is followed by another 24 weeks to continue looking closely at the safety profile and anti-HIV immune reaction after the last dose of study treatment.

NCT ID: NCT06430853 Not yet recruiting - Mental Health Issue Clinical Trials

Psychobiological Interventions in Pregnancy

PIP
Start date: September 2024
Phase: N/A
Study type: Interventional

This randomized control trial will evaluate whether a physical activity intervention can improve mental health and biologic markers of stress in pregnant people with depressive or anxiety symptoms. The study will enroll participants if they are presenting for prenatal care at Stanford Children's Health Obstetrics Clinic with a singleton gestation.

NCT ID: NCT06430840 Not yet recruiting - Cancer Clinical Trials

Addressing Financial and Social Needs Among Patients With Cancer

CAN-ASSIST
Start date: October 1, 2024
Phase: N/A
Study type: Interventional

Financial hardship and health-related social needs (e.g., insecurity about food, housing, transportation, utilities) are common among patients with cancer, resulting in health disparities in cancer outcomes. Our study will test the efficacy of a multicomponent financial navigation and counseling program delivered by a financial navigator (CostCOM), vs. direct patient access to financial education materials and comprehensive list of local resources in the absence of a financial navigator (FinEd) vs. practice usual care among newly diagnosed cancer patients who screen positive for financial hardship and social needs. Investigators anticipate that both CostCOM and FinEd compared to enhanced usual care will improve cost-related cancer care nonadherence, financial worry, health insurance literacy, quality of life and sleep quality and decrease number of missed appointments.